-
Mashup Score: 2ATO-ATRA Outperforms Chemo-ATRA in High-Risk APL - 4 month(s) ago
First-line treatment with ATO plus ATRA improved EFS over chemotherapy plus ATRA in patients with high-risk APL.
Source: www.cancertherapyadvisor.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 0ATRA/ATO Regimen Improves EFS in Newly Diagnosed, High-risk APL - 4 month(s) ago
Arsenic trioxide plus all-trans retinoic acid & idarubicin improved EFS vs standard ATRA and anthracycline-based chemotherapy in high-risk APL.
Source: www.onclive.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 1CAR T-Cell Therapy Is Safe, Feasible in Outpatient Setting for NHL - 4 month(s) ago
The administration of CAR T-cell therapy in the outpatient setting was deemed feasible and safe in patients with relapsed/refractory NHL.
Source: www.onclive.comCategories: General Medicine News, Onc News and JournalsTweet
First-line ATO plus ATRA improved EFS over chemotherapy plus ATRA in high-risk APL. These results, from the APOLLO trial, were presented at #EHA2024 by @UwePlatzbecker from @UKL_Leipzig. #leusm https://t.co/luccfPMaI5